Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy

Characterizing neutralizing antibody (NAb) responses in individuals infected with diverse HIV-1 strains is necessary to reveal the novel targets for regional preventive and therapeutic strategies development. We evaluated the prevalence, breadth, and potency of NAb responses in 98 CRF07_BC-infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xintao, Hu, Yuanyuan, Zhao, Chunhong, Gao, Hongmei, Greene, Kelli M., Ren, Li, Ma, Liying, Ruan, Yuhua, Sarzotti-Kelsoe, Marcella, Montefiori, David C., Hong, Kunxue, Shao, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384219/
https://www.ncbi.nlm.nih.gov/pubmed/28387330
http://dx.doi.org/10.1038/srep46308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384219/
https://www.ncbi.nlm.nih.gov/pubmed/28387330
http://dx.doi.org/10.1038/srep46308

Ejemplares similares